ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
125.785,37
0,94%
S&P 500
6.062,47
0,61%
US Dollar vs BRL
5,7812
-0,43%
Bitcoin
97.317,75
0,85%
Brent Oil
75,715
1,47%
As Melhores Corretoras Online
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. SurModics Inc (SRDX)

  7. SurModics Inc (SRDX) Notícias

SRDX

SurModics (SRDX)

SurModics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:SRDX
DataHoraFonteTítuloCódigoCompanhia
03/02/202509:00Business WireSurmodics Announces Successful Early Clinical Use of Pounce™ XL Thrombectomy System, Suitable for Non-Surgical Removal of Thrombi and Emboli from Iliac and Femoral ArteriesNASDAQ:SRDXSurModics Inc
30/01/202509:55Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SRDXSurModics Inc
30/01/202509:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRDXSurModics Inc
30/01/202509:00Business WireSurmodics Reports First Quarter of Fiscal Year 2025 Financial ResultsNASDAQ:SRDXSurModics Inc
28/01/202519:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRDXSurModics Inc
22/01/202519:15Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:SRDXSurModics Inc
19/12/202410:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SRDXSurModics Inc
19/12/202410:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SRDXSurModics Inc
26/11/202418:53Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SRDXSurModics Inc
20/11/202410:47Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SRDXSurModics Inc
14/11/202417:36Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:SRDXSurModics Inc
06/11/202409:00Business WireSurmodics Reports Fourth Quarter and Fiscal Year 2024 Financial ResultsNASDAQ:SRDXSurModics Inc
30/10/202415:30Business WireSurmodics Announces Early Results from PROWL Registry Study of Real-World Limb Ischemia Patients Treated with Pounce™ Thrombectomy SystemNASDAQ:SRDXSurModics Inc
01/10/202408:00Business WireSurmodics Receives FDA 510(k) Clearance for Pounce™ XL Thrombectomy System, Expanding the Pounce Thrombectomy Platform to Larger Peripheral Arteries up to 10 mm in DiameterNASDAQ:SRDXSurModics Inc
31/07/202408:00Business WireSurmodics Reports Third Quarter of Fiscal Year 2024 Financial ResultsNASDAQ:SRDXSurModics Inc
08/07/202417:28Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:SRDXSurModics Inc
17/06/202409:08PR Newswire (US)Kuehn Law Encourages, FFNW, HCP, CALB, and SRDX Investors to Contact Law FirmNASDAQ:SRDXSurModics Inc
10/06/202417:57Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SRDXSurModics Inc
10/06/202408:00Business WireSurmodics Awarded Thrombectomy Products Agreement with Premier, Inc.NASDAQ:SRDXSurModics Inc
29/05/202419:36PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Surmodics, Inc.NASDAQ:SRDXSurModics Inc
29/05/202408:00Business WireSurmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 MillionNASDAQ:SRDXSurModics Inc
24/05/202417:01Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:SRDXSurModics Inc
01/05/202408:00Business WireSurmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial GuidanceNASDAQ:SRDXSurModics Inc
19/04/202408:00Business WireSurmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1NASDAQ:SRDXSurModics Inc
27/02/202410:00Business WireSurmodics to Participate in Upcoming Investor Conferences in March and AprilNASDAQ:SRDXSurModics Inc
09/02/202413:20Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SRDXSurModics Inc
01/02/202409:00Business WireSurmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial GuidanceNASDAQ:SRDXSurModics Inc
22/01/202409:30Business WireSurmodics Announces Successful Early Clinical Use of Pounce™ LP (Low Profile) Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli Below the KneeNASDAQ:SRDXSurModics Inc
16/01/202409:30Business WireSurmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1NASDAQ:SRDXSurModics Inc
16/01/202409:30Business WireSurmodics to Host Virtual Annual Meeting of ShareholdersNASDAQ:SRDXSurModics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:SRDX

Seu Histórico Recente

BOV
AZEV4
AZEVEDO PN
BOV
IBOV
Índice Bovespa
BOV
RAIZ4
Raizen S.A PN
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
FICT3
Fictor Alimentos ON
BOV
RCSL4
RECRUSUL PN
BOV
PRIO3
PETRORIO ON
BOV
RNEW4
RENOVA PN
BOV
FNAM11
Fundo Invest Amazonia Fi...
BOV
GFSA3
GAFISA ON
BOV
AMOB3
Automob Participacoes ON
BOV
IDIV
Dividend
BOV
USIM5
USIMINAS PNA
BOV
TECN3
TECHNOS ON
BOV
BRAV3
Brava Energia ON
BOV
SEQL3
Sequoia Logistica e Tran... ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios